Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO

Publication date: December 2017
Source:Annals of Allergy, Asthma & Immunology, Volume 119, Issue 6
Author(s): John J. Oppenheimer, Paul A. Greenberger




http://ift.tt/2kaE5Gy